Dermatology.com Supports Lower, Predictable Pricing for Many
of Bausch Health's Prescription Dermatology Products at Walgreens
9,500 Retail Pharmacies
DEERFIELD, Ill. and
LAVAL, Quebec, Aug. 1, 2019 /CNW/ -- Walgreens and Bausch Health
Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") today announced a
modification to their existing fulfillment agreement to bring
patients lower prices, increased transparency and convenience for
many of Bausch Health's dermatology products. Under the expanded
agreement, Walgreens patients will have access to select
dermatology products from Bausch Health's first-of-its-kind
cash-pay prescription program, Dermatology.com, at lower flat cash
rates ranging from $50-$115. The program was launched under its Ortho
Dermatologics business in March 2019,
and will be available at more than 9,500 Walgreens U.S. retail
pharmacy locations by the end of August
2019.
"We launched dermatology.com to provide patients with direct
access to proven, branded dermatology medicines at predictable
prices," said Bill Humphries,
president, Ortho Dermatologics. "Through this new expanded
relationship with Walgreens, patients using the program will now
have a nationwide pharmacy option that is not only
welcoming and accessible, but will provide them with the
confidence that the cost they discuss with their physician will be
what they pay at the pharmacy. Together, we will continue to strive
to deliver on our commitment to provide the best possible access
and experience for patients who need these therapies."
The suite of products included in the cash-pay prescription
program treat a range of dermatological conditions, including
actinic keratosis (AK), acne, barrier repair (e.g. eczema
treatments), and corticosteroid-responsive diseases. These disease
states typically encounter insurance coverage challenges and high
prescription costs. All products included in the program are also
eligible for Flexible Spending Accounts or Health Saving
Accounts.
"Walgreens is committed to providing solutions that advance
patient care and cost savings for our customers and the healthcare
system," said Alex Gourlay, co-chief
operating officer for Walgreens Boots Alliance, Inc. "Through our
collaboration with Bausch Health, we are able to offer a set
pricing model that provides patients the security of knowing the
cost of their dermatology prescriptions each time they refill them
at Walgreens, while decreasing complexities and processes to allow
our pharmacists to focus on providing advice and support to
patients."
About Ortho Dermatologics
Ortho Dermatologics is one of the largest prescription dermatology
businesses dedicated to helping patients in the treatment of a
range of therapeutic areas, including psoriasis, actinic keratosis,
acne, atopic dermatitis and other dermatoses. The Ortho
Dermatologics portfolio includes several leading acne, anti-fungal
and corticosteroid-responsive dermatoses products. More information
can be found at www.ortho-dermatologics.com.
About Bausch Health
Bausch Health Companies Inc.
(NYSE/TSX: BHC) is a global company whose mission is to improve
people's lives with our health care products. We develop,
manufacture and market a range of pharmaceutical, medical device
and over-the-counter products, primarily in the therapeutic areas
of eye health, gastroenterology and dermatology. We are delivering
on our commitments as we build an innovative company dedicated to
advancing global health. More information can be found at
www.bauschhealth.com.
About Walgreens
Walgreens (walgreens.com), one of the
nation's largest drugstore chains, is included in the Retail
Pharmacy USA Division of Walgreens
Boots Alliance, Inc. (NASDAQ: WBA), the first global pharmacy-led,
health and wellbeing enterprise. Approximately 8 million customers
interact with Walgreens in stores and online each day, using the
most convenient, multichannel access to consumer goods and services
and trusted, cost-effective pharmacy, health and wellness services
and advice. As of August 31, 2018,
Walgreens operates 9,560 drugstores with a presence in all 50
states, the District of Columbia,
Puerto Rico and the U.S. Virgin Islands, along with its
omnichannel business, Walgreens.com. Approximately 400 Walgreens
stores offer Healthcare Clinic or other provider retail clinic
services.
Forward-Looking Statements
All statements in
this release that are not historical are forward-looking statements
made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. These forward-looking
statements are not guarantees of future performance and involve
risks, assumptions and uncertainties, including, but not limited
to, those related to the timing and effectiveness of collaboration
plans, the ability to realize the anticipated benefits of the
collaboration, competitive actions in the marketplace, and the
ability to achieve anticipated financial and operating results in
the amounts and at the times anticipated, as well as those
described in Item 1A (Risk Factors) of Walgreens Boots Alliance,
Inc.'s Form 10-K for its fiscal year ended August 31, 2018 and Form 10-Q for its fiscal
quarter ended February 28, 2019,
Bausch Health's Form 10-K for its fiscal year ended December 31, 2018, and subsequent documents that
Walgreens Boots Alliance, Inc. and Bausch Health file or furnish
with the Securities and Exchange Commission. Should one or more of
these risks or uncertainties materialize, or should underlying
assumptions prove incorrect, actual results may vary materially.
These forward-looking statements speak only as of the date they are
made. Except to the extent required by law, each of Walgreens Boots
Alliance, Inc., Walgreens and Bausch Health do not undertake, and
expressly disclaim, any duty or obligation to update publicly any
forward-looking statement after the date of this release, whether
as a result of new information, future events, changes in
assumptions or otherwise.
All product/brand names and or logos are trademarks of the
respective owners.
© 2019 Bausch Health Companies Inc. or its affiliates.
NPR.0158.USA.19
Walgreens
Contact:
|
Bausch Health
Contact:
|
Kelli
Teno
|
Arthur
Shannon
|
224-237-4526
|
514-856-3855
|
kelli.teno@walgreens.com
|
877-281-6642 (toll
free)
|
|
arthur.shannon@bauschhealth.com
|
View original content to download
multimedia:http://www.prnewswire.com/news-releases/bausch-health-expands-dermatology-cash-pay-prescription-program-to-walgreens-stores-nationwide-300894698.html
SOURCE Bausch Health Companies Inc.